InsidersTradesSigma
Follow the 에스디바이오센서 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has logged 12 reports. Market capitalisation: €716.5bn. The latest transaction was disclosed on 24 March 2026 (Purchase). Among the most active insiders: 조영식. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Listed on the XKRX market, 에스디바이오센서 is a company focused on the healthcare and pharmaceutical sector. It specializes in developing diagnostic and health monitoring solutions.